Search Results
Results found for "Juan Jose Fung"
- Dr. Juan José Fung | Dr. GPCR Ecosystem
Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Fung continued his Postdoctoral training in Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Unlock the Full Dr.
- Dr. Demet Araç | Dr. GPCR Ecosystem
Jose Rizo-Rey as a graduate student to elucidate the mechanisms of neurotransmitter release. postdoctoral studies and continued into his faculty position, despite initial challenges in securing funding Yamina posed the question of what advice Demet would give his younger self, but Demet responded that
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr. Josh C Snyder (2012) Dr.
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological What it felt like to see the first dose-response curves in native beta cells—and why that moment changed
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why Psychedelic Psilocybin is in Phase 3 trials for depression, and the early signal is striking — a single dose Bryan Roth describes the DARPA-funded effort his lab is leading to answer that question through structure-guided
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
Jean Martin Beaulieu About Dr. Jean Martin Beaulieu Dr. Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
Jean-Philippe Pin About Dr. Jean-Philippe Pin Jean-Philippe Pin participated in the discovery of metabotropic glutamate receptors Jean-Philippe Pin on the web LinkedIn ResearchGate CNRS Fondation Bettencourt Schueller FRC Neurodon
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
“It doesn’t matter how many cool, fun tools you have. Mentorship, Team Culture, and the Joy of Science Science is serious work, but Ben believes fun and collaboration “Science is fun. We produce great data, but we also joke around. That’s how we work best.” “We found something incredible — a tenfold shift in the methadone dose-response with our PAM.”
- Dr. Josh Pottel | Dr. GPCR Ecosystem
Josh Pottel About Dr. Josh Pottel "I lead Molecular Forecaster Inc. Josh Pottel on the web Molecular Forecaster LinkedIn BlueSky Google Scholar Twitter Dr.
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation products is Keltic Pharma Therapeutics Ltd , a biotechnology company co-founded by Andrew with series A funding
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
Hill—a large, interdisciplinary basic science department currently ranked 1st in the Nation in NIH funding Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Tall has been continuously funded by the NIH since receiving an early RO1 award at Rochester. He has continued funding at Michigan through the MIRA R35 program. Dr.
- Donate to Dr GPCR — Support the GPCR Community & University
Choose Your Impact Every Gift Moves the Science Forward Whether it's keeping Happy Hours free or funding Donate $25 $1,000 Catalyst Funds scholarships, retreats, and mentorship opportunities for early-career
- Eurofins DiscoverX | Dr. GPCR | Dr. GPCR Ecosystem
GLP-1R representative assay results (dose-response curves) for exendin-4, tirzepatide, and retatrutide A. cAMP dose–response; B. β-arrestin recruitment showing ligand bias; and C.
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
How a bell-shaped FSH dose-response curve led to one of the earliest demonstrations of biased GPCR signaling But for the researcher who first encountered it not as a theory but as an anomalous bell-shaped dose-response bell-shaped curve was a hypothesis, not an artifact When insect-cell-expressed FSH produced a bell-shaped dose-response
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
large, interdisciplinary basic science department consistently ranked in the Top 5 in the Nation in NIH funding Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
Claudia shared her experiences working in Sweden and Germany, and how she secured funding for her research They also touched on the potential for funding from external sources.
- Dr. GPCR Board | Dr. GPCR Ecosystem
and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly rose Trejo has been continuously funded by the NIH for >20 years and was a recipient of the prestigious American services, contributed analytic support resulting in authorship of numerous scientific publications and new funding
- Dr. Silvia Sposini | Dr. GPCR Ecosystem
I am currently funded by a postdoctoral fellowship from Wellcome Trust, working on a collaborative project
- Dr. Graham Ladds | Dr. GPCR Ecosystem
Warwick as a post-doc studying pro-hormone convertases before securing a 5-year independent fellowship funded
- Dr. Mark Connor | Dr. GPCR Ecosystem
Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
Remulate is the receptor she secured funding to study, the one her first PhD student built an entire discuss the cost of unpublished negative data, particularly for PhD students working within three-year funding
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
The "unknown unknowns" should change how we fund and train scientists Dr. GPR68 and the feedback loop in pancreatic cancer 19:46 Challenges of targeting GPCRs in oncology — funding
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
design for GPCR biology Academic entrepreneurship and the path from bench to phase 2 clinical trials Funding The spin-out - how a discovery became a phase 2 clinical trial in kidney disease 16:56 Why grant-only funding
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
Affinity Is a Snapshot; Time Is the Story Hoare draws a sharp analogy: running pharmacology dose-response "Imagine doing pharmacology dose-response experiments for twenty years without applying the sigmoid curve
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
Funded by a Wellcome Trust Seed Award, she investigated biased and compartmentalized G protein signaling
- Dr. Bruno Giros | Dr. GPCR Ecosystem
San Francisco, he joined the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly rose Trejo has been continuously funded by the NIH for >20 years and was a recipient of the prestigious American
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
Together with Ines Liebscher, Simone is leading an EU-funded COST Network on Adhesion GPCRs: CA18240





























